$ATRA +35% Premarket 🚀 🔹 Big biotech rebound move as traders pile back into the name 📈 🔹 Atara develops off-the-shelf cell therapies targeting difficult-to-

$ATRA +35% Premarket 🚀 🔹 Big biotech rebound move as traders pile back into the name 📈 🔹 Atara develops off-the-shelf cell therapies targeting difficult-to-treat cancers and autoimmune diseases 🧬 🔹 Key focus remains tabelecleucel / EBVALLO for EBV+ post-transplant lymphoproliferative disease ���…